{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:09:29Z","timestamp":1779221369783,"version":"3.51.4"},"reference-count":205,"publisher":"Elsevier","isbn-type":[{"value":"9780443345210","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","award":["R01AG060610"],"award-info":[{"award-number":["R01AG060610"]}],"id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apcsb.2025.10.014","type":"book-chapter","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:56:50Z","timestamp":1762307810000},"page":"157-195","source":"Crossref","is-referenced-by-count":0,"title":["Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-2129","authenticated-orcid":false,"given":"Subashchandrabose","family":"Chinnathambi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaraj","family":"Rangappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2025.10.014_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105874","article-title":"Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases","volume":"174","author":"Afridi","year":"2022","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib2","article-title":"Tau post-translational modifications: Dynamic transformers of Tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s41983-024-00845-5","article-title":"Unraveling Alzheimer\u2019s: The promise of aducanumab, lecanemab, and donanemab","volume":"60","author":"Ameen","year":"2024","journal-title":"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.15872","article-title":"Therapeutic equivalence of biosimilar and reference biologic drugs in rheumatoid arthritis: A systematic review and meta-analysis","volume":"6","author":"Ascef","year":"2023","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-021-00732-z","article-title":"Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer\u2019s disease","volume":"19","author":"Balmik","year":"2021","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151202","article-title":"Inter-relationship of histone deacetylase-6 with Tau-cytoskeletal organization and remodeling","volume":"101","author":"Balmik","year":"2022","journal-title":"European Journal of Cell Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-021-00736-9","article-title":"The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau","volume":"19","author":"Balmik","year":"2021","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroscience.2019.10.006","article-title":"The interaction between contactin and amyloid precursor protein and its role in Alzheimer\u2019s disease","volume":"424","author":"Bamford","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of Tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfab117.004","article-title":"FC 040Interim results of phase 1 AND 2 trials to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of bion-1301 in patients with IGA nephropathy","volume":"36","author":"Barratt","year":"2021","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13195-022-01110-8","article-title":"Gantenerumab: An anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer\u2019s disease","volume":"14","author":"Bateman","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"2-3","key":"10.1016\/bs.apcsb.2025.10.014_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pmic.201400169","article-title":"Investigation of phosphoproteome in RAGE signaling","volume":"15","author":"Batkulwar","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib13","article-title":"Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgG: Implications for Alzheimer\u2019s disease therapy","author":"Bellier","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib14","article-title":"Advancements and challenges in antiamyloid therapy for Alzheimer\u2019s disease: A comprehensive review","volume":"2024","author":"Beshir","year":"2024","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib15","unstructured":"Biogen. (2022). Lecanemab confirmatory phase 3 clarity ad study met primary endpoint, showing highly statistically significant reduction of clinical decline in large global clinical study of 1,795 participants with early Alzheimer\u2019s disease. Biogen. Retrieved September 27 from."},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","article-title":"Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N\u2011truncated Abeta in sporadic Alzheimer disease cases and mouse models","volume":"130","author":"Bouter","year":"2015","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2891-7-29","article-title":"The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk\/benefit profile","volume":"7","author":"Brambilla","year":"2008","journal-title":"Nutrition Journal"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib18","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/alz.13784","article-title":"The six brain-specific TAU isoforms and their role in Alzheimer\u2019s disease and related neurodegenerative dementia syndromes","volume":"20","author":"Buchholz","year":"2024","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.neurobiolaging.2007.05.002","article-title":"Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus","volume":"29","author":"Caffrey","year":"2008","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib20","first-page":"1163","article-title":"Mutations in presenilin 2 and its implications in Alzheimer\u2019s disease and other dementia-associated disorders","volume":"10","author":"Cai","year":"2015","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib21","article-title":"Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.661368","article-title":"Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau protein induce local conformational changes of the C-terminus and modulate tau self-assembly into fibrillar aggregates","volume":"14","author":"Cantrelle","year":"2021","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1158198","article-title":"Oxidative stress, free radicals and antioxidants: Potential crosstalk in the pathophysiology of human diseases","volume":"11","author":"Chaudhary","year":"2023","journal-title":"Frontiers in Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib24","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1039\/D3NR00398A","article-title":"Structurally different chemical chaperones show similar mechanical roles with independent molecular mechanisms","volume":"16","author":"Chaudhuri","year":"2024","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12987-024-00563-3","article-title":"Blood-brain barrier disruption: A culprit of cognitive decline?","volume":"21","author":"Che","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.014_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib29","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/ncomms4037","article-title":"Familial Alzheimer\u2019s mutations within APPTM increase A\u03b242 production by enhancing accessibility of \u03b5-cleavage site","volume":"5","author":"Chen","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: Associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of Tau with mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuroscience.2020.04.019","article-title":"G-Protein coupled receptors and Tau-different roles in Alzheimer\u2019s disease","volume":"438","author":"Chidambaram","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13578-020-00474-4","article-title":"Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation","volume":"10","author":"Chidambaram","year":"2020","journal-title":"Cell BioSciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151201","article-title":"G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia","volume":"101","author":"Chidambaram","year":"2022","journal-title":"European Journal of Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib35","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apcsb.2024.08.003","article-title":"Heat shock proteins regulates Tau protein aggregation in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib36","series-title":"Advances in protein chemistry and structural biology","article-title":"Histone deacetylase\u2019s regulates Tau function in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib37","series-title":"Advances in protein chemistry and structural biology","article-title":"Small molecule-mediated therapeutic approaches to target Tau and Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib38","series-title":"Advances in protein chemistry and structural biology","article-title":"Tau proteotasis in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib39","series-title":"Advances in protein chemistry and structural biology","article-title":"Lipid role in synapse and nuclear envelope-associated endocytic pathways in Tauopathy","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib40","series-title":"Advances in protein chemistry and structural biology","article-title":"Apolipoprotein E and Tau interaction in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib41","first-page":"467","article-title":"Chapter Fifteen - G-protein coupled receptors regulates Tauopathy in neurodegeneration","volume":"141","author":"Chinnathambi","year":"2024"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119477","article-title":"Tau aggregates improve the Purinergic receptor P2Y12-associated podosome rearrangements in microglial cells","volume":"1870","author":"Chinnathambi","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib43","first-page":"447","article-title":"Chapter Fourteen - The crosstalk between extracellular matrix proteins and Tau","volume":"141","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-0716-3629-9_6","article-title":"Photo-excited dyes: Emerging technique against Tau protein aggregation","volume":"2754","author":"Chinnathambi","year":"2024","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2021.09.003","article-title":"Implications of valosin-containing protein in promoting autophagy to prevent Tau aggregation","volume":"476","author":"Chinnathambi","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib46","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apcsb.2024.08.004","article-title":"The cross-talk between ApoE and Tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib47","series-title":"Advances in protein chemistry and structural biology","article-title":"Medicinal chemistry-based novel herapeutics for Tauopathies in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib48","series-title":"Advances in protein chemistry and structural biology","article-title":"Modifiable chemical risk factors for amyloid-\u03b2 and Tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib49","series-title":"Advances in protein chemistry and structural biology","article-title":"Lipids modulates Tau and amyloid-\u03b2 proteins in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib50","series-title":"Advances in protein chemistry and structural biology","article-title":"G-protein coupled receptors (GPCRs) interacts with Tau protein in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib51","series-title":"Advances in protein chemistry and structural biology","article-title":"Tau protein structure and dynamics","author":"Chinnathambi","year":"2024"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib52","series-title":"Advances in protein chemistry and structural biology","article-title":"Nuclear Tau accumulation in Alzheimer\u2019s disease","author":"Chinnathambi","year":"2024"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231209839","article-title":"Novel anti-amyloid-beta (A\u03b2) monoclonal antibody lecanemab for Alzheimer\u2019s disease: A systematic review","volume":"37","author":"Chowdhury","year":"2023","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102407","article-title":"Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases","volume":"20","author":"Collin","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: Current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nature Reviews Neurology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.10.014_bib57","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer\u2019s diseases","volume":"21","author":"Coppola","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.10.014_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315383","article-title":"Tau isoforms: Gaining insight into MAPT alternative splicing","volume":"23","author":"Corsi","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.014_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer\u2019s Disease Therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib60","doi-asserted-by":"crossref","unstructured":"Cummings, J., Zhou, Y., Lee, G., Zhong, K., Fonseca, J., & Cheng, F. (2024). [Not Available]. Alzheimers Dement (N Y), 10(2), e12465. https:\/\/doi.org\/10.1002\/trc2.12465 (Alzheimer\u2019s disease drug development pipeline: 2024.).","DOI":"10.1002\/trc2.12465"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13195-023-01321-7","article-title":"The therapeutic landscape of tauopathies: Challenges and prospects","volume":"15","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"34","key":"10.1016\/bs.apcsb.2025.10.014_bib62","doi-asserted-by":"crossref","first-page":"13982","DOI":"10.1021\/ja305470p","article-title":"\u03b2-Sheet core of tau paired helical filaments revealed by solid-state NMR","volume":"134","author":"Daebel","year":"2012","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107625","article-title":"Macrocyclic peptides derived from AcPHF6\u204e and AcPHF6 to selectively modulate the Tau aggregation","volume":"151","author":"Dangi","year":"2024","journal-title":"Bioorganic Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine--searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-019-1694-y","article-title":"Phagocytosis of full-length Tau oligomers by actin-remodeling of activated microglia","volume":"17","author":"Das","year":"2020","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuroscience.2020.09.024","article-title":"Actin-mediated microglial chemotaxis via G-protein coupled purinergic receptor in Alzheimer\u2019s disease","volume":"448","author":"Das","year":"2020","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/tra.12784","article-title":"Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis","volume":"22","author":"Das","year":"2021","journal-title":"Traffic (Copenhagen, Denmark)"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40259-019-00360-7","article-title":"Biosimilars: A value proposition","volume":"33","author":"de Mora","year":"2019","journal-title":"BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib69","doi-asserted-by":"crossref","first-page":"a006304","DOI":"10.1101\/cshperspect.a006304","article-title":"Presenilins and \u03b3-secretase: Structure, function, and role in Alzheimer disease","volume":"2","author":"De Strooper","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-0716-3629-9_11","article-title":"Biochemical and biophysical characterization of Tau and \u03b1-linolenic acid vesicles in vitro","volume":"2754","author":"Desale","year":"2024","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib71","doi-asserted-by":"crossref","unstructured":"Donanemab (Kisunla) for Alzheimer\u2019s disease. (2024). The Medical Letter on Drugs and Therapeutics, 66(1709), 129\u2013131. https:\/\/doi.org\/10.58347\/tml.2024.1709a.","DOI":"10.58347\/tml.2024.1709a"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123171","article-title":"Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells","volume":"234","author":"Dubey","year":"2023","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112970","article-title":"The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation","volume":"221","author":"Dubey","year":"2023","journal-title":"Colloids and Surfaces. B, Biointerfaces"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40259-019-00395-w","article-title":"Identifying key benefits in european off-patent biologics and biosimilar markets: It is not only about price!","volume":"34","author":"Dutta","year":"2020","journal-title":"BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib75","unstructured":"Eisai Co., L. (2024). Eisai presents latest clinical findings suggesting inhibition of tau propagation by anti-mtbr Tau antibody e2814 at the 17th clinical trials on Alzheimer\u2019s disease conference (ctad). Eisai Co., Ltd. Retrieved October 31 from https:\/\/www.eisai.com\/news\/2024\/news202480.html."},{"key":"10.1016\/bs.apcsb.2025.10.014_bib76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.02.002.2009","article-title":"Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer\u2019s disease","volume":"2","author":"Engmann","year":"2009","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib77","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1016\/j.apsb.2023.07.010","article-title":"Oxidative stress, the blood-brain barrier and neurodegenerative diseases: The critical beneficial role of dietary antioxidants","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.5429","article-title":"Patient out-of-pocket costs for biologic drugs after biosimilar competition","volume":"5","author":"Feng","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.014_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111676","article-title":"Linking the amyloid, Tau, and mitochondrial hypotheses of Alzheimer\u2019s disease and identifying promising drug targets","volume":"12","author":"Fi\u0161ar","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.014_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.10.014_bib81","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401704R","article-title":"High-molecular-weight oligomer tau (HMWoTau) species are dramatically increased in Braak-stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005)","volume":"38","author":"Fukumoto","year":"2024","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib82","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2082145","article-title":"The role of oxidative stress in physiopathology and pharmacological treatment with Pro- and antioxidant properties in chronic diseases","volume":"2020","author":"Garc\u00eda-S\u00e1nchez","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Molecular Neurodegeneration"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.014_bib85","article-title":"Exploring the role of reactive oxygen species in the pathogenesis and pathophysiology of Alzheimer\u2019s and Parkinson\u2019s disease and the efficacy of antioxidant treatment","volume":"13","author":"Gogna","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.10.014_bib86","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: A promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijbiomac.2020.02.278","article-title":"Cobalt-based metal complexes prevent repeat Tau aggregation and nontoxic to neuronal cells","volume":"152","author":"Gorantla","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-6598-4_2","article-title":"Global conformation of Tau protein mapped by Raman spectroscopy","volume":"1523","author":"Gorantla","year":"2017","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6598-4_1","article-title":"Conformational dynamics of intracellular Tau protein revealed by CD and SAXS","volume":"1523","author":"Gorantla","year":"2017","journal-title":"Methods in Molecular Biology"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.10.014_bib90","doi-asserted-by":"crossref","first-page":"11131","DOI":"10.1021\/acsomega.9b03497","article-title":"Amyloid-\u03b2-derived peptidomimetics inhibits Tau aggregation","volume":"6","author":"Gorantla","year":"2021","journal-title":"ACS Omega"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib91","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1007\/s12035-020-02084-0","article-title":"The crosstalk between pathological Tau phosphorylation and mitochondrial dysfunction as a key to understanding and treating Alzheimer\u2019s disease","volume":"57","author":"Guha","year":"2020","journal-title":"Molecular Neurobiology"},{"issue":"s1","key":"10.1016\/bs.apcsb.2025.10.014_bib92","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-\u03b2 and Tau proteins in Alzheimer\u2019s disease: Confuting the amyloid cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib93","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3204519","article-title":"Amyloid-\u03b2-induced dysregulation of AMPA receptor trafficking","volume":"2016","author":"Guntupalli","year":"2016","journal-title":"Neural Plasticity"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.10.014_bib94","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regeneration Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2121-10-81","article-title":"The proline-rich domain of tau plays a role in interactions with actin","volume":"10","author":"He","year":"2009","journal-title":"BMC Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib97","article-title":"The role of hydrogen therapy in Alzheimer\u2019s disease management: Insights into mechanisms, administration routes, and future challenges","volume":"168","author":"He","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12325-021-01951-z","article-title":"The economic impact of originator-to-biosimilar non-medical switching in the real-world setting: A systematic literature review","volume":"39","author":"Hillhouse","year":"2022","journal-title":"Advances in Therapy"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102348","article-title":"Donanemab, another anti-Alzheimer\u2019s drug with risk and uncertain benefit","volume":"99","author":"H\u00f8ilund-Carlsen","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib100","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.43030","article-title":"Enhancing health care affordability: Strategies for accelerating biosimilar uptake","volume":"76","author":"Hong","year":"2024","journal-title":"Arthritis & Rheumatology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib101","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","article-title":"CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease","volume":"29","author":"Horie","year":"2023","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib102","article-title":"Microtubule organization is essential for maintaining cellular morphology and function","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajme.2017.09.001","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alexandria Journal of Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104739","article-title":"Insulin deficiency promotes formation of toxic amyloid-\u03b242 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer\u2019s disease model","volume":"137","author":"Imamura","year":"2020","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib106","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","article-title":"Alzheimer\u2019s disease, a multifactorial disorder seeking multitherapies","volume":"6","author":"Iqbal","year":"2010","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib107","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib108","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: Antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Archives of Toxicology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.014_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090410","article-title":"The breakthrough of biosimilars: A twist in the narrative of biological therapy","volume":"9","author":"Kabir","year":"2019","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib110","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/antiox13121508","article-title":"The role of dietary antioxidants, food supplements and functional foods for energy enhancement in healthcare professionals","volume":"13","author":"Kalogerakou","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib111","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib112","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","article-title":"Donanemab: First approval","volume":"84","author":"Kang","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102091","article-title":"Role of diet and exercise in aging, Alzheimer\u2019s disease, and other chronic diseases","volume":"91","author":"Khemka","year":"2023","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib114","article-title":"Disorders of endogenous and exogenous antioxidants in neurological diseases","volume":"12","author":"Korczowska-\u0141\u0105cka","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.11.009","article-title":"The cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems","volume":"52","author":"Kvien","year":"2022","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2024.11.019","article-title":"Safeguarding the brain from oxidative damage","volume":"226","author":"Lee","year":"2025","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib119","article-title":"Tau ubiquitination in Alzheimer\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-3-8","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"3","author":"Liu","year":"2008","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib121","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphys.2018.00477","article-title":"Role of ROS and nutritional antioxidants in human diseases","volume":"9","author":"Liu","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib122","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1582-4934.2009.00897.x","article-title":"Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems","volume":"14","author":"L\u00fc","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"22","key":"10.1016\/bs.apcsb.2025.10.014_bib123","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2146\/ajhp130119","article-title":"Biosimilars: Implications for health-system pharmacists","volume":"70","author":"Lucio","year":"2013","journal-title":"American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib124","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.10.014_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/cells13181527","article-title":"Immunotherapy for Parkinson\u2019s disease and Alzheimer\u2019s disease: A promising disease-modifying therapy","volume":"13","author":"Mahboob","year":"2024","journal-title":"Cells"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. small molecules: Drug costs and patient access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Medicine in Drug Discovery"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib127","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: Implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020235","article-title":"An overview of biosimilars-development, quality, regulatory issues, and management in healthcare","volume":"17","author":"Mascarenhas-Melo","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.0959-9673.2005.00434.x","article-title":"Metals and amyloid-beta in Alzheimer\u2019s disease","volume":"86","author":"Maynard","year":"2005","journal-title":"International Journal of Experimental Pathology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/JPD-239901","article-title":"Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2023 update","volume":"13","author":"McFarthing","year":"2023","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.10.014_bib131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/biom9030105","article-title":"Structure and functions of microtubule associated proteins Tau and MAP2c: Similarities and differences","volume":"9","author":"Melkov\u00e1","year":"2019","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.014_bib133","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.10.014_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194661","article-title":"The role of protein misfolding and Tau oligomers (TauOs) in Alzheimer\u2019s disease (AD)","volume":"20","author":"Mroczko","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Molecular Cancer Therapeutics"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib136","first-page":"3","article-title":"Biosimilar cost savings in the United States: Initial experience and future potential","volume":"7","author":"Mulcahy","year":"2018","journal-title":"RAND Health Quarterly"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib137","first-page":"43","article-title":"Alzheimer\u2019s disease puzzle: Delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging and disease"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib138","unstructured":"Network, R.A. (2011). Introduction to Biosimilar Medicines Second ed.\u00a0\u3008https:\/\/researchadvocacy.org\/sites\/default\/files\/resources\/Biosimilar%20Medicines6_4Final.pdf\u3009."},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib139","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2006.06.023","article-title":"Alpha- and beta-secretase activity as a function of age and beta-amyloid in down syndrome and normal brain","volume":"28","author":"Nistor","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib140","article-title":"Oxidative stress and antioxidants in neurodegenerative disorders","volume":"12","author":"Olufunmilayo","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib141","unstructured":"Packaging,\u00a0M. (2024).\u00a0Medical Packaging Medical Packaging. https:\/\/medpak.com\/biosimilar-vs-generic-drugs\/#part-2."},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib142","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib143","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib144","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-024-00417-w","article-title":"Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer\u2019s disease","volume":"13","author":"Penny","year":"2024","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib145","unstructured":"Pfizer. (2022). Biologics vs. Biosimilars: Understanding the Difference. Pfizer. https:\/\/www.pfizer.com\/news\/articles\/harnessing_the_power_of_ai_to_detect_attr_cm."},{"key":"10.1016\/bs.apcsb.2025.10.014_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.969547","article-title":"Amyloid precursor protein (APP) and amyloid \u03b2 (A\u03b2) interact with cell adhesion molecules: Implications in Alzheimer\u2019s disease and normal physiology","volume":"10","author":"Pfundstein","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.014_bib147","article-title":"On the potential role of the antioxidant couple vitamin E\/selenium taken by the oral route in skin and hair health","volume":"11","author":"Pincemail","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib148","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: Harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.10.014_bib149","article-title":"The importance of dietary antioxidants on oxidative stress, meat and milk production, and their preservative aspects in farm animals: Antioxidant action, animal health, and product quality-invited review","volume":"12","author":"Ponnampalam","year":"2022","journal-title":"Animals (Basel)"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.014_bib150","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acscentsci.4c01319","article-title":"Post-translational modifications control phase transitions of Tau","volume":"10","author":"Powell","year":"2024","journal-title":"ACS Central Science"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib151","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1091\/mbc.E17-06-0429","article-title":"Tau can switch microtubule network organizations: From random networks to dynamic and stable bundles","volume":"29","author":"Prezel","year":"2018","journal-title":"Molecular Biology of the Cell"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib152","article-title":"Antioxidants in Alzheimer\u2019s disease: Current therapeutic significance and future prospects","volume":"11","author":"Pritam","year":"2022","journal-title":"Biology (Basel)"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib153","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5639\/gabij.2024.1302.008","article-title":"Increasing adoption of quality-assured biosimilars to address access challenges in low- and middle-income countries","volume":"13","author":"Pritha","year":"2024","journal-title":"Generics and Biosimilars Initiative (GaBI)"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib154","series-title":"Advances in protein chemistry and structural biology","article-title":"Nuclear podosomes regulates cellular migration in Tau and Alzheimer\u2019s disease","author":"Qureshi","year":"2024"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119275","article-title":"Histone deacetylase-6 modulates Tau function in Alzheimer\u2019s disease","volume":"1869","author":"Qureshi","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib156","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neuroscience"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib157","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regeneration Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: A crucial factor in Alzheimer\u2019s disease","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centre"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib159","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues","volume":"133","author":"Samudra","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib160","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib161","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nurt.2008.05.006","article-title":"Tau-based treatment strategies in neurodegenerative diseases","volume":"5","author":"Schneider","year":"2008","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.10.014_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060708","article-title":"Drug development for Alzheimer\u2019s and Parkinson\u2019s disease: Where do we go now?","volume":"16","author":"Sequeira","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib163","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fphys.2020.00694","article-title":"Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Frontiers in Physiology"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib164","article-title":"Linking oxidative stress and proteinopathy in Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.59556\/japi.72.0755","article-title":"Current update on promising new anti-Alzheimer\u2019s drugs in different phases of clinical development: Where exactly are we lacking?","volume":"72","author":"Sharma","year":"2024","journal-title":"The Journal of the Association of Physicians of India"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/NAN.0000000000000528","article-title":"Biosimilars: From production to patient","volume":"47","author":"Sheridan","year":"2024","journal-title":"Journal of Infusion Nursing: the Official Publication of the Infusion Nurses Society"},{"issue":"s1","key":"10.1016\/bs.apcsb.2025.10.014_bib167","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.3233\/JAD-231238","article-title":"Tau immunotherapies for Alzheimer\u2019s disease and related tauopathies: Status of trials and insights from preclinical studies","volume":"101","author":"Sigurdsson","year":"2024","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib168","article-title":"ROS generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.10.014_bib169","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer\u2019s disease amyloid beta peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12031-018-1111-5","article-title":"Prion-like propagation of post-translationally modified Tau in Alzheimer\u2019s disease: A hypothesis","volume":"65","author":"Sonawane","year":"2018","journal-title":"Journal of Molecular Neuroscience: MN"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-191348","article-title":"P301 L, an FTDP-17 mutant, exhibits enhanced glycation in vitro","volume":"75","author":"Sonawane","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.10.014_bib172","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.18632\/oncotarget.27963","article-title":"Epigallocatechin-3-gallate modulates Tau post-translational modifications and cytoskeletal network","volume":"12","author":"Sonawane","year":"2021","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib173","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-017-0489-6","article-title":"Atypical, non-standard functions of the microtubule associated Tau protein","volume":"5","author":"Sotiropoulos","year":"2017","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib174","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fphar.2019.00809","article-title":"Nocebo in biosimilars and generics in neurology: A systematic review","volume":"10","author":"Spanou","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.014_bib175","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031757","article-title":"Presenilin: A multi-functional molecule in the pathogenesis of Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"25","author":"Sun","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib177","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.014_bib178","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1007\/s12035-022-02734-5","article-title":"SUMO1 modification of Tau in progressive supranuclear palsy","volume":"59","author":"Takamura","year":"2022","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib179","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: A genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.10.014_bib180","first-page":"699","article-title":"Potential of biosimilars to increase access to biologics: Considerations for advanced practice providers in oncology","volume":"9","author":"Tinsley","year":"2018","journal-title":"Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib181","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib182","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","article-title":"High-molecular weight A\u03b2 oligomers and protofibrils are the predominant A\u03b2 species in the native soluble protein fraction of the AD brain","volume":"16","author":"Upadhaya","year":"2012","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib183","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Current Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib184","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-Amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: Pitfalls and promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2023.2178414","article-title":"Lecanemab (BAN2401): An anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","volume":"32","author":"Vitek","year":"2023","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib186","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112915","article-title":"Small molecule therapeutics for tauopathy in Alzheimer\u2019s disease: Walking on the path of most resistance","volume":"209","author":"Wang","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.10.014_bib188","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Annals of Translational Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib189","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting agents for cancer treatment: Seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm \u2013 Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.10.014_bib190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib191","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cpt.2753","article-title":"The role of PD biomarkers in biosimilar development - to get the right answer one must first ask the right question","volume":"113","author":"Woollett","year":"2023","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib192","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","article-title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Wu","year":"2023","journal-title":"European Journal of Medical Research"},{"issue":"48","key":"10.1016\/bs.apcsb.2025.10.014_bib193","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1074\/jbc.RA119.010178","article-title":"Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations","volume":"294","author":"Xia","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.10.014_bib194","doi-asserted-by":"crossref","first-page":"255","DOI":"10.37349\/en.2024.00048","article-title":"Current therapeutics for Alzheimer\u2019s disease and clinical trials","volume":"3","author":"Xiao","year":"2024","journal-title":"Exploration of Neuroscience"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.10.014_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29122812","article-title":"Role of Tau protein in neurodegenerative diseases and development of its targeted drugs: A literature review","volume":"29","author":"Yang","year":"2024","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.10.014_bib196","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-2010-100816","article-title":"Amyloid-\u03b2 production via cleavage of amyloid-\u03b2 protein precursor is modulated by cell density","volume":"22","author":"Zhang","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib197","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.10.014_bib198","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib199","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: Challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.10.014_bib200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: New perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib201","article-title":"The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Endocrinology\u00a0(Lausanne)"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in Alzheimer\u2019s disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib203","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib204","doi-asserted-by":"crossref","DOI":"10.1002\/alz.082771","article-title":"E2814: An anti\u2010tau therapy engages its CNS target and affects the downstream tangle\u2010specific biomarker MTBR\u2010tau243 in dominantly inherited Alzheimer\u2019s disease","volume":"19","author":"Zhou","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/bs.apcsb.2025.10.014_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.572308","article-title":"The role of copper in Tau-related pathology in Alzheimer\u2019s disease","volume":"13","author":"Zub\u010di\u0107","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Immunomodulators - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:46:13Z","timestamp":1779219973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345210"],"references-count":205,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.10.014","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}